-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OX5eCtqGtWsqGrnpQDfQ1xO2QwASmxDw9j5tMbtwJF/DwOp1J4EgvUqxdF17QHO5 XG3Jsnojf/FGUoni4I6M2w== 0001123292-07-000539.txt : 20070619 0001123292-07-000539.hdr.sgml : 20070619 20070619172150 ACCESSION NUMBER: 0001123292-07-000539 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070618 FILED AS OF DATE: 20070619 DATE AS OF CHANGE: 20070619 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MILNE GEORGE M JR CENTRAL INDEX KEY: 0001179552 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19131 FILM NUMBER: 07929483 BUSINESS ADDRESS: STREET 1: 251 BALARDVALE ST. CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIMMUNE INC /DE CENTRAL INDEX KEY: 0000873591 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 521555759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-398-0000 MAIL ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-06-18 1 0000873591 MEDIMMUNE INC /DE MEDI 0001179552 MILNE GEORGE M JR ONE MEDIMMUNE WAY GAITHERSBURG MD 20878 1 0 0 0 Stock Option (right to buy) 23.81 2007-06-18 4 D 0 30000 0 D 2015-04-01 Common Stock 30000 0 D Stock Option (right to buy) 27.12 2007-06-18 4 D 0 30000 0 D 2015-06-30 Common Stock 30000 0 D Stock Option (right to buy) 27.12 2007-06-18 4 D 0 25000 0 D 2016-06-30 Common Stock 25000 0 D This option, which provided for vesting in four equal annual installments beginning on 04/01/06, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $34.19, representing the difference between the exercise price of the option and $58.00 per share. This option, which provided for vesting in four equal annual installments beginning on 06/30/06, was cancelled in the merger in exchange for a cash payment of $30.88 per share, representing the difference between the exercise price of the option and $58.00 per share. This option, which provided for vesting in four equal annual installments beginning on 06/30/07, was cancelled in the merger in exchange for a cash payment of $30.88 per share, representing the difference between the exercise price of the option and $58.00 per share. /s/ William C. Bertrand, Jr., Attorney-in-Fact 2007-06-19 -----END PRIVACY-ENHANCED MESSAGE-----